X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (242) 242
dichloroacetic acid - therapeutic use (236) 236
animals (179) 179
male (150) 150
index medicus (124) 124
female (108) 108
dichloroacetic acid (93) 93
dichloroacetic acid - pharmacology (90) 90
metabolism (86) 86
dichloroacetate (81) 81
rats (71) 71
mice (58) 58
apoptosis (55) 55
cancer (54) 54
adult (53) 53
acetates - therapeutic use (50) 50
acidosis, lactic - drug therapy (48) 48
middle aged (47) 47
pharmacology & pharmacy (47) 47
lactates - blood (45) 45
toxicology (44) 44
glycolysis (43) 43
cell line, tumor (39) 39
mitochondria (39) 39
oncology (36) 36
lactic acid (35) 35
dichloroacetic acid - administration & dosage (33) 33
lactates - metabolism (32) 32
glucose - metabolism (28) 28
in-vitro (28) 28
pyruvate dehydrogenase complex - metabolism (28) 28
acidosis - drug therapy (27) 27
apoptosis - drug effects (27) 27
glucose (27) 27
lactic-acidosis (27) 27
child (26) 26
trichloroacetic-acid (26) 26
trichloroethylene (26) 26
infant (25) 25
pyruvic acid (25) 25
aged (24) 24
bicarbonates - therapeutic use (24) 24
cell biology (24) 24
kinases (23) 23
metabolites (23) 23
mitochondria - metabolism (23) 23
adolescent (22) 22
article (22) 22
dogs (22) 22
dose-response relationship, drug (22) 22
multidisciplinary sciences (22) 22
sodium dichloroacetate (22) 22
clinical neurology (21) 21
medicine (21) 21
research (21) 21
congenital lactic-acidosis (20) 20
hydrogen-ion concentration (20) 20
hypoxia (20) 20
liver - metabolism (20) 20
neoplasms - drug therapy (20) 20
rats, sprague-dawley (20) 20
acidosis, lactic - etiology (19) 19
antineoplastic agents - pharmacology (19) 19
cancer-cells (19) 19
cardiac & cardiovascular systems (19) 19
dehydrogenases (19) 19
dichloroacetic acid - pharmacokinetics (19) 19
health aspects (19) 19
lactate (19) 19
mitochondria - drug effects (19) 19
physiological aspects (19) 19
rodents (19) 19
antineoplastic agents - therapeutic use (18) 18
liver (18) 18
time factors (18) 18
care and treatment (17) 17
cell proliferation - drug effects (17) 17
dichloroacetic acid - toxicity (17) 17
disease models, animal (17) 17
enzymes (17) 17
research article (17) 17
therapy (17) 17
toxicity (17) 17
tumors (17) 17
analysis (16) 16
cell survival - drug effects (16) 16
dca (16) 16
dichloroacetic acid - adverse effects (16) 16
environmental sciences (16) 16
growth (16) 16
risk assessment (16) 16
child, preschool (15) 15
controlled clinical-trial (15) 15
glucose metabolism (15) 15
glycolysis - drug effects (15) 15
hemodynamics - drug effects (15) 15
liver - drug effects (15) 15
myocardium - metabolism (15) 15
oxidation (15) 15
public, environmental & occupational health (15) 15
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (353) 353
Japanese (11) 11
German (5) 5
French (3) 3
Chinese (2) 2
Polish (2) 2
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 10/2008, Volume 99, Issue 7, pp. 989 - 994
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 2015, Volume 5, Issue 1, pp. 7762 - 7762
Journal Article
CIRCULATION, ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1214 - 1224
Journal Article
Science Translational Medicine, ISSN 1946-6234, 10/2017, Volume 9, Issue 413, p. eaao4583
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 08/2016, Volume 235, pp. 125 - 133
Local recurrence following surgery in cancer treatment remains a major clinical challenge. To increase antitumor activity but maintain toxicity in an... 
Dichloroacetate | Local cancer recurrence | Oxaliplatin | Time-programmed release | Local treatment | Multilayered electrospun nanofibers | APOPTOSIS | MESHES | RESECTION | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | DELIVERY | STRATEGIES | CELL LUNG-CANCER | NANOPARTICLES | CISPLATIN | PHARMACOLOGY & PHARMACY | CARCINOMA | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - chemistry | Neoplasms - surgery | Humans | Nanofibers - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Dichloroacetic Acid - chemistry | Dichloroacetic Acid - therapeutic use | Drug Delivery Systems | Tissue Distribution | Organoplatinum Compounds - administration & dosage | Nanofibers - administration & dosage | Organoplatinum Compounds - chemistry | Nanofibers - chemistry | Cell Survival - drug effects | Nanofibers - ultrastructure | Microscopy, Electron, Scanning | Neoplasm Recurrence, Local - prevention & control | Antineoplastic Agents - chemistry | Neoplasms - drug therapy | Drug Synergism | Dichloroacetic Acid - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Line, Tumor | Drug Liberation | Mice | Organoplatinum Compounds - therapeutic use | Prevention | Textile fabrics | Antimitotic agents | Relapse | Antineoplastic agents | Cervical cancer | Cancer | Index Medicus
Journal Article
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 2009, Volume 121, Issue 1, pp. 69 - 88
Pulmonary arterial hypertension is a progressive, fatal disease. Current treatments including prostanoids, endothelin-1 (ET-1) antagonists, and... 
Pulmonary arterial hypertension | Vascular remodelling | Vasoconstriction | VASOACTIVE-INTESTINAL-PEPTIDE | NITRIC-OXIDE SYNTHASE | RHO-KINASE INHIBITOR | CONTINUOUS INTRAVENOUS EPOPROSTENOL | SOLUBLE GUANYLATE-CYCLASE | CONTROLLED CLINICAL-TRIAL | ENDOTHELIAL PROGENITOR CELLS | ACTIVATED-RECEPTOR-GAMMA | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | 5-HYDROXYTRYPTAMINE TRANSPORTER GENE | Cyclic GMP - pharmacology | Serotonin - physiology | Pneumonia - physiopathology | Cyclic GMP - physiology | Endothelial Cells | Humans | Receptor Protein-Tyrosine Kinases - physiology | Bone Morphogenetic Protein Receptors - drug effects | Hypertension, Pulmonary - physiopathology | Adrenomedullin - pharmacology | Pancreatic Elastase - antagonists & inhibitors | Serotonin - pharmacology | Stem Cells - metabolism | Dichloroacetic Acid - therapeutic use | rho-Associated Kinases - antagonists & inhibitors | Vasoactive Intestinal Peptide - pharmacology | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Hypertension, Pulmonary - drug therapy | Vasoactive Intestinal Peptide - therapeutic use | NFATC Transcription Factors - metabolism | Pancreatic Elastase - drug effects | Bone Morphogenetic Protein Receptors - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Drug Discovery | NFATC Transcription Factors - drug effects | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Pneumonia - drug therapy | Adrenomedullin - therapeutic use | Cyclic GMP - metabolism | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Dichloroacetic Acid - pharmacology
Journal Article